Tenderwize
Back to tender search

Open-House-Biologika-Rabattverträge 2025-21 - Teriparatid

Techniker Krankenkasse·Hamburg, Germany·Deadline Aug 30, 2027 · 377 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-21 - Teriparatid

50/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Why this score?

Opportunity

50 / 100

Complexity

30 / 100

Risk factors

No estimated value or framework maximum means potential volume is unknown.

Electronic submission is not allowed via the portal; requires email with QES or postal submission with scanned copy.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Aug 2027
  • Pharmaceutical discount agreement for Teriparatid
  • Supply of the active substance to German statutory health insurance funds
Show full summary

Open-House procedure by Techniker Krankenkasse and other German health insurers to conclude discount agreements (Rabattverträge) for the active substance Teriparatid. The procedure allows any eligible pharmaceutical entrepreneur to join at any time during the contract period (01.09.2025 to 31.08.2027). No exclusive rights are granted. The notice explicitly states this is not a public procurement subject to EU procurement law; legal disputes fall under social courts. No estimated value, award criteria, or detailed submission documents were provided in the structured data or XML notice.

Risks

No estimated value or framework maximum means potential volume is unknown.

Electronic submission is not allowed via the portal; requires email with QES or postal submission with scanned copy.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical entrepreneur (pharmazeutischer Unternehmer) per § 4 Abs. 18 AMG
  • Must have a valid marketing authorization for the medicinal product per § 21 AMG
  • Must have registered seat in Germany, EU, or EEA

Requirements may be incomplete.

Award Criteria

Lot 1

No award criteria specified; in open-house, contracts are concluded with all eligible participants.

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open-House-Biologika-Rabattverträge 2025-21 - Teriparatid

Conclusion of pharmaceutical discount agreements for Teriparatid under § 130a Abs. 8 SGB V via an open-house procedure. No negotiation, uniform terms. Contract duration max 24 months from 01.09.2025 to 31.08.2027.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Aug 2025 - Aug 2027

Category

Pharmaceutical products

Award Criteria

No award criteria specified; in open-house, contracts are concluded with all eligible participants.

Deadline

Deadline Aug 30, 2027

Procurement Details

Publication date
13 Jul 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
457552-2025

Documents (1)

Similar tenders